Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
fantastic people, great benefits, remote environment, patient focused, noble mission, bring your dog to work, growth and opportunities
O que você mais gosta nos lideres?
transparent, care about employees, smart and passionate, inspiring
O que faz você mais feliz no trabalho?
the people, the entrepreneurial work,
Qual é a melhor parte das suas compensações?
generous bonus and opportunity to earn more stock based on performance
Quais são algumas das melhores coisas da sua equipe?
collaborative, mission focused, willing to do what it takes, smart and fun
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
focus on DEI, community week events bring teams and people together, transparent communications, celebrating successes and people, focus on people first
Other Employee Reviews for Karyopharm Therapeutics
×